Your Input: | |||||
GML | Glycosylphosphatidylinositol anchored molecule like. (158 aa) | ||||
PINLYP | Phospholipase A2 inhibitor and LY6/PLAUR domain containing. (232 aa) | ||||
CD59 | CD59 glycoprotein; Potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore (By similarity). (130 aa) | ||||
LYPD5 | LY6/PLAUR domain containing 5. (250 aa) | ||||
CD177 | CD177 molecule. (437 aa) | ||||
PLAUR | Urokinase plasminogen activator surface receptor; Acts as a receptor for urokinase plasminogen activator. Plays a role in localizing and promoting plasmin formation. Mediates the proteolysis-independent signal transduction activation effects of U-PA. It is subject to negative-feedback regulation by U-PA which cleaves it into an inactive form (By similarity). (335 aa) | ||||
LYPD2 | LY6/PLAUR domain containing 2. (127 aa) | ||||
ACRV1 | Acrosomal vesicle protein 1. (285 aa) | ||||
LYNX1-SLURP2 | LYNX1-SLURP2 readthrough. (97 aa) | ||||
TEX101 | Testis expressed 101. (262 aa) | ||||
LY6H | Lymphocyte antigen 6H; Believed to act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity. In vitro inhibits alpha-3:beta-4- containing nAChRs maximum response. May play a role in the intracellular trafficking of alpha-7-containing nAChRs and may inhibit their expression at the cell surface. Seems to inhibit alpha-7/CHRNA7 signaling in hippocampal neurons (By similarity). (161 aa) | ||||
LYPD4 | LY6/PLAUR domain containing 4. (246 aa) | ||||
LYPD8 | LY6/PLAUR domain containing 8. (238 aa) |